Many MM risk factors and genetic mutations are linked to dysregulated TGF (transforming growth factor)-signaling pathway and NF-kB activation, leading to increased osteopontin activation with up-regulated MMPs’ expression and activation in MM (such as MMP-9) [2]. The gene discussed is MMP9; the disease is Miyoshi myopathy.